Ginkgo Bioworks Stock (NYSE:DNA)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$6.45

52W Range

$5.26 - $75.20

50D Avg

$7.80

200D Avg

$23.63

Market Cap

$361.95M

Avg Vol (3M)

$1.42M

Beta

1.10

Div Yield

-

DNA Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Industry

Biotechnology

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

1,218

IPO Date

Apr 19, 2021

Website

DNA Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 23	Dec 22	Dec 21
Service	$78.97M	$298.58M	$177.81M
Product	$28.95M	$35.45M	$23.04M
Foundry Revenue	-	$143.67M	$112.99M

Fiscal year ends in Dec 23 | Currency in USD

DNA Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$251.46M	$477.71M	$313.84M
Operating Income	$-864.41M	$-2.21B	$-1.83B
Net Income	$-892.87M	$-2.11B	$-1.84B
EBITDA	$-864.41M	$-2.18B	$-1.88B
Basic EPS	$-0.56	$-1.25	$-1.35
Diluted EPS	$-0.56	$-1.25	$-1.35

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 12, 24 | 10:02 PM

Q2 24Aug 08, 24 | 9:02 PM

Q1 24May 09, 24 | 12:00 AM

Peer Comparison

Ticker	Company
CWBR	CohBar, Inc.
AVRO	AVROBIO, Inc.
OCEA	Ocean Biomedical, Inc.
HEPA	Hepion Pharmaceuticals, Inc.
ELEV	Elevation Oncology, Inc.
ENVB	Enveric Biosciences, Inc.